MCID: GST044
MIFTS: 61

Gastritis

Categories: Gastrointestinal diseases, Immune diseases, Infectious diseases

Aliases & Classifications for Gastritis

MalaCards integrated aliases for Gastritis:

Name: Gastritis 12 30 56 6 45 15 17 74 64
Acute Gastric Mucosal Erosion 12 74
Erosive Gastropathy 12 74
Erosive Gastritis 12 74
Idiopathic Erosive/hemorrhagic Gastritis 74
Gastritis Erosive 56

Classifications:



External Ids:

Disease Ontology 12 DOID:4029
MeSH 45 D005756
NCIt 51 C26780
SNOMED-CT 69 4556007
ICD10 34 K29.7

Summaries for Gastritis

PubMed Health : 64 About gastritis: The membranes lining the stomach wall protect it from acid and germs. If this protective lining is irritated or damaged, it can become inflamed. Long-lasting inflammations can further damage the stomach lining and lead to stomach (gastric) ulcers.Inflammation of the stomach lining is called gastritis. It is usually caused by certain bacteria or anti-inflammatory medication.There are two kinds of gastritis: acute and chronic. Acute gastritis is typically accompanied by very noticeable stomach and bowel problems that usually go away again on their own after a few days. Chronic gastritis, on the other hand, sometimes goes unnoticed. People may only realize they have it when complications like stomach ulcers arise.

MalaCards based summary : Gastritis, also known as acute gastric mucosal erosion, is related to autoimmune atrophic gastritis and alcoholic gastritis, and has symptoms including dyspepsia and gastric irritation. An important gene associated with Gastritis is PGC (Progastricsin), and among its related pathways/superpathways are Innate Immune System and Defensins. The drugs Amoxicillin and Metronidazole have been mentioned in the context of this disorder. Affiliated tissues include testes, t cells and colon.

Disease Ontology : 12 A stomach disease that is an inflammation of the lining of the stomach.

Wikipedia : 77 Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a... more...

Related Diseases for Gastritis

Diseases in the Gastritis family:

Autoimmune Gastritis Viral Gastritis
Bacterial Gastritis

Diseases related to Gastritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 349)
# Related Disease Score Top Affiliating Genes
1 autoimmune atrophic gastritis 34.3 CHGA GAST
2 alcoholic gastritis 34.2 IL1B PTGS2
3 atrophic gastritis 33.1 ADH7 CHGA CXCL8 GAST GHRL IL1B
4 dyspepsia 32.1 CXCL8 GHRL HRH2 PGC PTGS2
5 helicobacter pylori infection 31.9 CXCL1 CXCL8 GAST IL1B MUC6 S100A8
6 colitis 30.9 CXCL8 IL1B NOS2 PTGS2
7 esophagitis 30.8 CXCL8 HRH2 IL1B PTGS2
8 gastric cancer 30.8 GAST IL1B IL1RN MUC6 PTGS2 S100A8
9 duodenal ulcer 30.7 CXCL8 GAST HRH2 IL1B IL1RN S100A8
10 gastric ulcer 30.7 CXCL8 GAST HRH2 IL1B IL1RN PTGS2
11 stomach disease 30.5 CXCL8 GAST GHRL HRH2 IL1B MUC6
12 arthritis 30.5 CXCL8 IL1B IL1RN PTGS2
13 peptic ulcer disease 30.4 CXCL8 GAST GHRL HRH2 IL1B IL1RN
14 zollinger-ellison syndrome 30.4 CHGA GAST HRH2
15 crohn's colitis 30.3 CXCL8 IL1B NOS2
16 gastric adenocarcinoma 30.3 CHGA CXCL8 GAST IL1B IL1RN PTGS2
17 peptic esophagitis 30.2 CXCL8 HRH2 IL1B
18 gastric neuroendocrine neoplasm 30.2 CHGA GAST
19 gastroesophageal reflux 30.1 CXCL8 GAST GHRL HRH2 IL1B PTGS2
20 pharyngitis 30.0 CXCL8 IL1B PTGS2
21 gastrointestinal system disease 29.8 CXCL8 GAST GHRL IL1B PTGS2 S100A8
22 rheumatoid arthritis 29.8 CXCL1 CXCL8 IL1B IL1RN PTGS2
23 intestinal disease 29.8 CXCL8 GHRL IL1B PTGS2
24 barrett esophagus 29.7 GAST MUC6 PTGS2 TFF2
25 active peptic ulcer disease 29.7 HRH2 PTGS2
26 gastric tubular adenocarcinoma 29.6 CHGA MUC6 PTGS2
27 pneumonia 29.3 CXCL1 CXCL8 IL1B
28 collagenous gastritis 12.5
29 gastritis, familial giant hypertrophic 12.4
30 bacterial gastritis 12.4
31 herpetic gastritis 12.4
32 granulomatous gastritis 12.3
33 chronic erosive gastritis 12.2
34 lymphocytic gastritis 12.2
35 eosinophilic gastritis 12.2
36 autoimmune gastritis 12.2
37 necrotizing gastritis 12.2
38 pediatric collagenous gastritis 12.1
39 viral gastritis 12.1
40 cystic fibrosis with helicobacter pylori gastritis, megaloblastic anemia, and mental retardation 12.1
41 fungal gastritis 12.0
42 eosinophilic enteropathy 11.9
43 pernicious anemia 11.4
44 lubani-al saleh-teebi syndrome 11.2
45 immunodeficiency 12 11.0
46 duodenitis 10.9
47 gastroduodenitis 10.6
48 exudative glomerulonephritis 10.5 CXCL8 IL1B
49 bile reflux 10.4
50 recurrent corneal erosion 10.4 CXCL8 IL1B

Graphical network of the top 20 diseases related to Gastritis:



Diseases related to Gastritis

Symptoms & Phenotypes for Gastritis

UMLS symptoms related to Gastritis:


dyspepsia, gastric irritation

Drugs & Therapeutics for Gastritis

PubMedHealth treatment related to Gastritis: 64

If you notice that stress, alcohol or nicotine affect your symptoms, you can try to change your diet, stop drinking alcohol, quit smoking and reduce stress in everyday life. If these lifestyle changes are not enough to relieve the symptoms, medication is considered.Gastritis not caused by Helicobacter pylori is usually treated with medication to lower acid levels. Depending on the type and severity of the symptoms, the following drugs can be used:Proton pump inhibitors (PPIs) like omeprazole or pantoprazole reduce the production of stomach acid.H2 blockers such as ranitidine and famotidine also reduce acid production.Antacids like aluminium hydroxide or magnesium hydroxide neutralize the acid already in your stomach.If the gastritis is caused by a Helicobacter infection and is accompanied by noticeable symptoms, it will be treated using a combination of two or three antibiotics and an acid-lowering proton pump inhibitor.If the gastritis is caused by an NSAID painkiller, it is a good idea to consult your doctor about switching to a different painkiller or combining it with an acid-lowering medication. Should an NSAID have to be taken regularly, it is possible to take it along with acid-lowering medication from the start, as a precaution.

Drugs for Gastritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 351)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 26787-78-0 33613
2
Metronidazole Approved Phase 4,Phase 3,Phase 2,Not Applicable 443-48-1 4173
3
Clarithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 81103-11-9 84029
4
Rabeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 117976-89-3 5029
5
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 73590-58-6 4594
6
Esomeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 161796-78-7, 119141-88-7, 161973-10-0 9568614 4594
7
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
8
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
9
Mirtazapine Approved Phase 4 61337-67-5, 85650-52-8 4205
10
Histamine Approved, Investigational Phase 4,Phase 3,Phase 1 51-45-6 774
11
Hydroxocobalamin Approved Phase 4,Not Applicable 13422-51-0 11953898 15589840
12
Dexlansoprazole Approved, Investigational Phase 4,Phase 3 138530-94-6, 103577-45-3 9578005
13
Lansoprazole Approved, Investigational Phase 4,Phase 3 103577-45-3 3883
14
Norgestimate Approved, Investigational Phase 4,Phase 3 35189-28-7 6540478
15
Tetracycline Approved, Vet_approved Phase 4,Not Applicable 60-54-8 5353990
16
Moxifloxacin Approved, Investigational Phase 4,Phase 3 354812-41-2, 151096-09-2 152946
17
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3 50-28-2 5757
18
Ethinyl Estradiol Approved Phase 4,Phase 3 57-63-6 5991
19
Polyestradiol phosphate Approved Phase 4,Phase 3 28014-46-2
20
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 564-25-0 54671203
21
Ofloxacin Approved Phase 4,Phase 3,Phase 1,Not Applicable 82419-36-1 4583
22
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 100986-85-4 149096
23
Wormwood Approved, Experimental Phase 4,Phase 2
24
Ethanol Approved Phase 4,Phase 2,Not Applicable 64-17-5 702
25
Sucralfate Approved Phase 4 54182-58-0
26
Methylcobalamin Approved, Experimental, Investigational Phase 4 13422-55-4
27
Amphotericin B Approved, Investigational Phase 4 1397-89-3 14956 5280965
28
Titanium dioxide Approved Phase 4 13463-67-7
29
Sodium Citrate Approved, Investigational Phase 4,Phase 3,Phase 1 68-04-2
30
Potassium Citrate Approved, Investigational, Vet_approved Phase 4
31
Licorice Approved Phase 4,Phase 2,Phase 3
32
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
33
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
34
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 93-14-1 3516
35
Mannitol Approved, Investigational Phase 4,Not Applicable 69-65-8 453 6251
36
Pantoprazole Approved Phase 4,Phase 3,Not Applicable 102625-70-7 4679
37
Verapamil Approved Phase 4 52-53-9 2520
38
Ranitidine Approved Phase 4 66357-59-3, 66357-35-5 3001055
39
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 59-30-3 6037
40
Cyanocobalamin Approved, Nutraceutical Phase 4,Not Applicable 68-19-9 44176380
41
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 1 77-92-9 311
42
Ginseng Approved, Investigational, Nutraceutical Phase 4 50647-08-0
43
Calcium Approved, Nutraceutical Phase 4,Phase 3,Phase 1 7440-70-2 271
44
Serine Approved, Nutraceutical Phase 4 56-45-1 5951
45
Coenzyme Q10 Approved, Investigational, Nutraceutical Phase 4 303-98-0 5281915
46 Rebamipide Investigational Phase 4,Phase 3,Phase 2,Phase 1 90098-04-7
47
Cobalamin Experimental Phase 4,Not Applicable 13408-78-1 6857388
48
Furazolidone Experimental, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 67-45-8 5323714 3435
49 Mosapride Investigational Phase 4,Phase 1 112885-41-3
50
Sulforaphane Investigational Phase 4 4478-93-7, 142825-10-3 5350

Interventional clinical trials:

(show top 50) (show all 287)
# Name Status NCT ID Phase Drugs
1 Concomitant Therapy of H. Pylori Unknown status NCT01922765 Phase 4 amoxicillin, clarithromycin, metronidazole, rabeprazole
2 Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice Unknown status NCT01273441 Phase 4 PPI, amoxicillin, metronidazole and clarithromycin;PPI, amoxicillin, metronidazole and clarithromycin
3 14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication Unknown status NCT01464060 Phase 4 PPI, amoxicillin, metronidazole and clarithromycin;PPI, amoxicillin, metronidazole and clarithromycin
4 Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia Unknown status NCT02134405 Phase 4 Rebamipide;Placebo (for Esomeprazole);Esomeprazole
5 Steroids in the Postoperative Transient Hypoparathyroidism Total Thyroidectomy Unknown status NCT02652884 Phase 4 phosphate and betamethasone acetate, 2 mL.;saline 0.9% NaCl
6 Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia Unknown status NCT03004118 Phase 4 Placebo Oral Tablet;Ursochol oral tablet
7 Mirtazapine Versus Placebo in Functional Dyspepsia Unknown status NCT01240096 Phase 4 Mirtazapine
8 A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab. Completed NCT01817556 Phase 4 Stillen Tab.;Mucosta Tab.
9 Clinical Effect of Rebamipide on Chronic Gastritis Completed NCT02393430 Phase 4 Rebamipide
10 Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients Completed NCT02356679 Phase 4 Eupasidin-s Tab;Stillen Tab.
11 A Study to Evaluate the Efficacy of Teprenone On Chinese Patients With Chronic Non-Atrophic Erosive Gastritis Completed NCT01284647 Phase 4 Teprenone capsule and placebo of sucralfate;Sucralfate and placebo of teprenone
12 To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG) Completed NCT01474044 Phase 4 Gastropylor Complex Capsules
13 Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients Completed NCT01119768 Phase 4 Esomeprazole;Esomeprazole
14 Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer Completed NCT01190657 Phase 4 Selbex;Selbex
15 Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment Completed NCT00534443 Phase 4
16 Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy Completed NCT02633930 Phase 4 Berberine;clarithromycin;Bismuth;Lansoprazole;amoxicillin
17 Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy Completed NCT02296021 Phase 4 Berberine;Bismuth;esomeprazole;amoxicillin;clarithromycin
18 High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication Completed NCT01888237 Phase 4 Double dose of PPI;sequence of drug use
19 Efficacy and Safety of Probiotic Treatment as a Supportive Therapy in Eradication of H. Pylori Completed NCT01969331 Phase 4
20 A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection Completed NCT01219764 Phase 4 Rabeprazole, metronidazole, Clarithromycin, Amoxicillin
21 Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection Completed NCT02835560 Phase 4 Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy;Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapy
22 Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy Completed NCT01792700 Phase 4 esomeprazole;tripotassium dicitrate bismuthate;metronidazole;tetracycline;moxifloxacin;amoxicillin
23 Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori Infection Completed NCT03524833 Phase 4 Metronidazole;Lansoprazole, Amoxicillin, Metronidazole
24 Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection Completed NCT03521726 Phase 4 Amoxicillin;Rabeprazole, Amoxicillin
25 Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection Completed NCT03516669 Phase 4 Clarithromycin;Amoxicillin, Clarithromycin
26 Intraluminal Therapy for Helicobacter Pylori Infection Completed NCT03124420 Phase 4 Lansoprazole;Amoxicillin;Clarithromycin
27 Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection Completed NCT02401477 Phase 4 Ilaprazole + Amoxicillin
28 The Efficacy and Safety Study of Rikkunshito in Patients With Functional Dyspepsia Completed NCT02037776 Phase 4 Rikkunshito;Rikkunshito placebo
29 Efficacy of Banhasasim-tang on Functional Dyspepsia Completed NCT00987805 Phase 4
30 Gastric Functions & Proton Pump Inhibitor( PPI) Study Completed NCT00951431 Phase 4 Esomeprazole;Placebo
31 Lansoprazole Versus Mosapride for Functional Dyspepsia Completed NCT00663897 Phase 4 lansoprazole;mosapride
32 The Effect of Anti-inflammatory Analgesics on Pain Following Hallux Valgus Surgery Completed NCT00733421 Phase 4 etoricoxib;tramadol
33 Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality Recruiting NCT02047994 Phase 4 Triple therapy
34 Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Recruiting NCT02175186 Phase 4 ALBIS;Placebo
35 Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets Recruiting NCT03857425 Phase 4 Clostridum Butyricum Capsule;Bacillus Coagulans Tablets;Clostridum Butyricum Capsule plus Bacillus Coagulans Tablets
36 Concomitant Versus Hybrid Regimen for H. Pylori Eradication Recruiting NCT03592069 Phase 4 10 day concomitant regimen;14 day hybrid regimen
37 Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy Recruiting NCT03609892 Phase 4 Berberine;Amoxicillin;Esomeprazole;Bismuth;Tetracycline;Furazolidone;Esomeprazole;Bismuth
38 Bismuth Based Quadruple Therapy 10 Days in Children Recruiting NCT03299725 Phase 4 colloidal bismuth sub-citrate
39 The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers Recruiting NCT03342456 Phase 4 Doxycycline Hyclate Enteric-Coated Capsules;Amoxicillin Capsules;Ilaprazole Enteric-Coated Tablets;Furazolidone Tablets;Potassium Citrate Tablets
40 The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori Recruiting NCT03220542 Phase 4 Probiotics;Esomeprazole;Amoxicillin;Clarithromycin
41 Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation Recruiting NCT02067182 Phase 4 Dabigatran
42 Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety Active, not recruiting NCT02679508 Phase 4 Vonoprazan;Lansoprazole
43 The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study Not yet recruiting NCT02933229 Phase 4 H. pylori eradication
44 Intraluminal Mono-antibiotic Therapy for Helicobacter Pylori Infection - A Comparison of Levofloxacin Powder and Levofloxacin Solution Not yet recruiting NCT03832465 Phase 4 Levofloxacin film-coated tablet;Levofloxacin intravenous solution
45 Intragastric pH and Bismuth Effect for H. Pylori Eradication Not yet recruiting NCT02894892 Phase 4 (A)Bismuth;(B)Bismuth;(C)Bismuth;(D)Esomeprazole and Bismuth;(E)Esomeprazole and Bismuth;(F)Esomeprazole and Bismuth
46 International Clinical Study of Zhizhu Kuanzhong Capsule Not yet recruiting NCT03825692 Phase 4 Zhizhu Kuanzhong Capsule;Zhizhu Kuanzhong Placebo Capsule
47 Lansoprazole Preventing Gastroduodenal Stress Ulcerations Terminated NCT00220909 Phase 4 Lansoprazole
48 A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy Terminated NCT02788123 Phase 4 bismuth tripotassium dicitrate;pantoprazole
49 Efficacy and Safety of Coenzyme Q10 in the Treatment of Statin-Associated Myalgia Terminated NCT00590408 Phase 4
50 The Clinical Significance of Acid Rebound in Functional Dyspepsia Terminated NCT01373970 Phase 4 Placebo;Pantoprazole + Placebo

Search NIH Clinical Center for Gastritis

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: gastritis

Genetic Tests for Gastritis

Genetic tests related to Gastritis:

# Genetic test Affiliating Genes
1 Gastritis 30

Anatomical Context for Gastritis

MalaCards organs/tissues related to Gastritis:

42
Testes, T Cells, Colon, Liver, Thyroid, B Cells, Bone

Publications for Gastritis

Articles related to Gastritis:

(show top 50) (show all 3630)
# Title Authors Year
1
Reduced Prevalence of Alcoholic Gastritis in Hospitalized Individuals Who Consume Cannabis. ( 30536396 )
2019
2
Association of Appendicitis, Helicobacter Pylori Positive Gastritis and Thrombotic Thrombocytopenic Purpura in an Adolescent. ( 30700693 )
2019
3
Gastric Neuroendocrine Tumor and Duodenal Gastrinoma With Chronic Autoimmune Atrophic Gastritis. ( 30531243 )
2019
4
The incidence of neoplasia in patients with autoimmune metaplastic atrophic gastritis: a renewed call for surveillance. ( 30598594 )
2019
5
The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective. ( 30639639 )
2019
6
Diagnostic performance of serum pepsinogen assay for the prediction of atrophic gastritis and gastric neoplasms: Protocol for a systematic review and meta-analysis. ( 30681610 )
2019
7
Prevalence and determinants of serological evidence of atrophic gastritis among Arab and Jewish residents of Jerusalem: a cross-sectional study. ( 30700483 )
2019
8
Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs. ( 30736753 )
2019
9
Notoginsenoside R1 (NGR1) Attenuates Chronic Atrophic Gastritis in Rats. ( 30757999 )
2019
10
Correction: Grading of Atrophic Gastritis is Useful for Risk Stratification in Endoscopic Screening for Gastric Cancer. ( 30844907 )
2019
11
Insights into Pediatric Autoimmune Gastritis: Is There a Role for Helicobacter Pylori Infection? ( 30664567 )
2019
12
Subacute Combined Degeneration, Pernicious Anemia and Gastric Neuroendocrine Tumor Occured Simultaneously Caused by Autoimmune Gastritis. ( 30740042 )
2019
13
An Unusual Case of Collagenous Gastritis: Incidental Finding in a Patient Presenting with Dysphagia. ( 30805226 )
2019
14
Three case reports of collagenous gastritis in children: Lessons for an endoscopic and histologic approach to mucosal nodularity of the stomach. ( 30882690 )
2019
15
Gastroesophageal reflux symptoms and microscopic esophagitis in a cohort of consecutive patients affected by atrophic body gastritis: a pilot study. ( 30638085 )
2019
16
Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging. ( 30773732 )
2019
17
Long-term gastric cancer risk in male smokers with atrophic corpus gastritis. ( 30700174 )
2019
18
Multiple infections by EBV, HCMV and Helicobacter pylori are highly frequent in patients with chronic gastritis and gastric cancer from Southwest Mexico: An observational study. ( 30653141 )
2019
19
An ethanol extract of the rhizome of Atractylodes chinensis exerts anti-gastritis activities and inhibits Akt/NF-κB signaling. ( 30218812 )
2019
20
Checkpoint Inhibitor-induced Hemorrhagic Gastritis with Pembrolizumab. ( 30353060 )
2019
21
Genetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis: a prospective cross-sectional study in Thailand. ( 30507657 )
2019
22
Comparison of body condition score and other minimally invasive biomarkers between dogs with gastric carcinoma and dogs with chronic gastritis. ( 30605380 )
2019
23
Hemorrhagic shock resulting from varicella zoster gastritis in a non-immunocompromised patient. ( 30690214 )
2019
24
Recognizing emphysematous gastritis. ( 30694948 )
2019
25
Genetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis in Thai population. ( 30707146 )
2019
26
Antitumor response to microscopic melanoma in the gastric mucosa mimicking ipilimumab-induced gastritis. ( 30744698 )
2019
27
Lymphocytic Gastritis Overshadowed by Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. ( 30773956 )
2019
28
Can neopterin be a useful immune biomarker for differentiating gastric intestinal metaplasia and gastric atrophy from non-atrophic non-metaplastic chronic gastritis? ( 30795853 )
2019
29
CagL polymorphisms D58/K59 are predominant in Helicobacter pylori strains isolated from Mexican patients with chronic gastritis. ( 30805032 )
2019
30
Accuracy of Different Rapid Urease Tests in Comparison with Histopathology in Patients with Endoscopic Signs of Gastritis. ( 30820016 )
2019
31
Correlations of the Gastric and Duodenal Microbiota with Histological, Endoscopic, and Symptomatic Gastritis. ( 30841591 )
2019
32
Sarcina Organisms: A Potential Cause of Emphysematous Gastritis in a Patient With Gastroparesis. ( 30848737 )
2019
33
Epidemiology of Sulcascaris sulcata (Nematoda: Anisakidae) ulcerous gastritis in the Mediterranean loggerhead sea turtle (Caretta caretta). ( 30859311 )
2019
34
Evaluation of emotional, behavioral problems and family functioning in adolescents with chronic gastritis. ( 30869487 )
2019
35
The role of high sensitive C-reactive protein and histopathological evaluation in chronic gastritis patients with or without Helicobacter pylori infection. ( 30916140 )
2019
36
ADAM proteases involved in inflammation are differentially altered in patients with gastritis or ulcer. ( 29434796 )
2018
37
Decrease in<i>PSCA</i>expression caused by<i>Helicobacter pylori</i>infection may promote progression to severe gastritis. ( 29423095 )
2018
38
The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis. ( 29847892 )
2018
39
The First Reported Case of Cytomegalovirus Gastritis in a Patient With End-Stage Renal Disease. ( 29891044 )
2018
40
Momordica charantia polysaccharides ameliorate oxidative stress, inflammation, and apoptosis in ethanol-induced gastritis in mucosa through NF-kB signaling pathway inhibition. ( 29307809 )
2018
41
Collagenous gastritis: a rare disease with distinctive endoscopicA findings. ( 29476843 )
2018
42
The key is in the air: transthoracic echocardiogram leading to diagnose emphysematous gastritis. ( 29401257 )
2018
43
Impact of SNP-SNP interactions of DNA repair gene<i>ERCC5</i>and metabolic gene<i>GSTP1</i>on gastric cancer/atrophic gastritis risk in a Chinese population. ( 29434449 )
2018
44
Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. ( 29306868 )
2018
45
Low PG I/II ratio as a marker of atrophic gastritis: Association with nutritional and metabolic status in healthy people. ( 29768385 )
2018
46
Combined Extracts of <i>Artemisia</i> and Green Tea, Mitigated Alcoholic Gastritis Via Enhanced Heat-shock Protein 27. ( 29566474 )
2018
47
Mucosal-Associated Invariant T Cells Augment Immunopathology and Gastritis in Chronic<i>Helicobacter pylori</i>Infection. ( 29378910 )
2018
48
Psychological distress in patients with chronic atrophic gastritis: the risk factors, protection factors, and cumulative effect. ( 29353492 )
2018
49
Polymorphism rs7521584 in miRa89429 is associated with the severity of atrophic gastritis in patients with HelicobacterA pylori infection. ( 29956763 )
2018
50
Multiplex serology of Helicobacter pylori antigens in detection of current infection and atrophic gastritis - A simple and cost-efficient method. ( 29665437 )
2018

Variations for Gastritis

ClinVar genetic disease variations for Gastritis:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 CEL NM_001807.4(CEL): c.1975G> C (p.Ala659Pro) single nucleotide variant Uncertain significance rs587780309 GRCh37 Chromosome 9, 135946855: 135946855
2 CEL NM_001807.4(CEL): c.1975G> C (p.Ala659Pro) single nucleotide variant Uncertain significance rs587780309 GRCh38 Chromosome 9, 133071468: 133071468

Expression for Gastritis

Search GEO for disease gene expression data for Gastritis.

Pathways for Gastritis

Pathways related to Gastritis according to GeneCards Suite gene sharing:

(show all 23)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.91 CHGA CXCL1 CXCL8 DEFA5 DEFB1 IL1B
2
Show member pathways
12.2 CHGA DEFA5 DEFB1 S100A8
3
Show member pathways
12.16 CXCL8 IL1B NOS2 PTGS2
4
Show member pathways
12.1 CXCL1 CXCL8 IL1B PTGS2 S100A8
5
Show member pathways
11.97 CXCL8 IL1B IL1RN NOS2 PTGS2
6 11.82 CXCL1 IL1B PTGS2
7 11.81 CXCL8 IL1B NOS2 PTGS2
8 11.8 CXCL1 CXCL8 IL1B
9 11.75 CXCL8 IL1B PTGS2
10 11.72 CXCL1 CXCL8 IL1B
11 11.72 CXCL1 CXCL8 IL1B NOS2
12 11.64 CXCL1 CXCL8 IL1B NOS2
13 11.63 CXCL1 CXCL8 IL1B NOS2 PTGS2
14 11.61 CXCL8 IL1B NOS2
15 11.44 CXCL1 CXCL8 IL1B
16 11.39 CXCL8 NOS2 PTGS2
17
Show member pathways
11.36 CXCL8 IL1B NOS2 PTGS2
18
Show member pathways
11.29 PGA3 PGA4 PGA5
19 11.2 CXCL1 IL1B IL1RN NOS2 PTGS2
20 10.89 CXCL8 PTGS2
21 10.71 CXCL1 CXCL8 IL1B IL1RN PTGS2
22 10.38 GAST MUC6
23 10.19 GAST HRH2

GO Terms for Gastritis

Cellular components related to Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.73 CHGA CXCL1 CXCL8 DEFA5 DEFB1 GAST
2 extracellular region GO:0005576 9.55 ADH7 CHGA CXCL1 CXCL8 DEFA5 DEFB1
3 secretory granule lumen GO:0034774 9.5 DEFA5 GHRL S100A8
4 Golgi lumen GO:0005796 9.43 DEFA5 DEFB1 MUC6
5 multivesicular body lumen GO:0097486 9.33 PGA3 PGA4 PGA5

Biological processes related to Gastritis according to GeneCards Suite gene sharing:

(show all 28)
# Name GO ID Score Top Affiliating Genes
1 regulation of signaling receptor activity GO:0010469 9.97 CXCL1 CXCL8 GAST GHRL IL1B IL1RN
2 defense response to bacterium GO:0042742 9.92 CHGA DEFA5 DEFB1 NOS2 S100A8
3 inflammatory response GO:0006954 9.91 CXCL1 CXCL8 IL1B IL1RN PTGS2 S100A8
4 response to lipopolysaccharide GO:0032496 9.89 IL1B NOS2 PTGS2 S100A8
5 chemotaxis GO:0006935 9.88 CXCL1 CXCL8 DEFB1 S100A8
6 defense response GO:0006952 9.86 CXCL1 CXCL8 DEFA5 DEFB1
7 response to bacterium GO:0009617 9.81 ADH7 DEFB1 NOS2
8 defense response to Gram-positive bacterium GO:0050830 9.8 CHGA DEFA5 DEFB1
9 cytokine-mediated signaling pathway GO:0019221 9.8 CXCL1 CXCL8 IL1B IL1RN NOS2 PTGS2
10 chemokine-mediated signaling pathway GO:0070098 9.78 CXCL1 CXCL8 TFF2
11 defense response to Gram-negative bacterium GO:0050829 9.78 CHGA DEFA5 DEFB1 NOS2
12 defense response to fungus GO:0050832 9.71 CHGA DEFA5 S100A8
13 antimicrobial humoral immune response mediated by antimicrobial peptide GO:0061844 9.71 CXCL1 CXCL8 DEFA5 DEFB1
14 innate immune response in mucosa GO:0002227 9.69 DEFA5 DEFB1 NOS2
15 antimicrobial humoral response GO:0019730 9.67 CHGA DEFA5 DEFB1 S100A8
16 response to ethanol GO:0045471 9.64 ADH7 S100A8
17 maintenance of gastrointestinal epithelium GO:0030277 9.62 MUC6 TFF2
18 negative regulation of blood vessel diameter GO:0097756 9.61 CHGA PTGS2
19 response to glucocorticoid GO:0051384 9.6 IL1RN PTGS2
20 positive regulation of fever generation GO:0031622 9.58 IL1B PTGS2
21 peptidyl-cysteine S-nitrosylation GO:0018119 9.57 NOS2 S100A8
22 protein catabolic process GO:0030163 9.56 PGA3 PGA4 PGA5 PGC
23 memory GO:0007613 9.46 HRH2 PTGS2
24 digestion GO:0007586 9.46 PGA3 PGA4 PGA5 PGC
25 neutrophil chemotaxis GO:0030593 9.35 CXCL1 CXCL8 IL1B IL1RN S100A8
26 ovulation GO:0030728 9.32 PTGS2
27 cellular response to lipopolysaccharide GO:0071222 9.1 CXCL1 CXCL8 DEFA5 IL1B IL1RN NOS2
28 immune response GO:0006955 10.02 CXCL1 CXCL8 DEFB1 HRH2 IL1B IL1RN

Molecular functions related to Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.26 CXCL1 CXCL8 IL1B IL1RN
2 interleukin-1 receptor binding GO:0005149 9.16 IL1B IL1RN
3 aspartic-type endopeptidase activity GO:0004190 8.92 PGA3 PGA4 PGA5 PGC

Sources for Gastritis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....